BR112023025789A2 - Nitroxolina para uso no tratamento de neurofibroma cutâneo - Google Patents
Nitroxolina para uso no tratamento de neurofibroma cutâneoInfo
- Publication number
- BR112023025789A2 BR112023025789A2 BR112023025789A BR112023025789A BR112023025789A2 BR 112023025789 A2 BR112023025789 A2 BR 112023025789A2 BR 112023025789 A BR112023025789 A BR 112023025789A BR 112023025789 A BR112023025789 A BR 112023025789A BR 112023025789 A2 BR112023025789 A2 BR 112023025789A2
- Authority
- BR
- Brazil
- Prior art keywords
- nitroxoline
- treatment
- cutaneous neurofibroma
- neurofibroma
- cutaneous
- Prior art date
Links
- 201000004404 Neurofibroma Diseases 0.000 title abstract 3
- RJIWZDNTCBHXAL-UHFFFAOYSA-N nitroxoline Chemical compound C1=CN=C2C(O)=CC=C([N+]([O-])=O)C2=C1 RJIWZDNTCBHXAL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005131 nitroxoline Drugs 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108224.3A GB202108224D0 (en) | 2021-06-09 | 2021-06-09 | Treatment |
| PCT/GB2022/051442 WO2022258972A1 (en) | 2021-06-09 | 2022-06-09 | Nitroxoline for use in the treatment of cutaneous neurofibroma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025789A2 true BR112023025789A2 (pt) | 2024-02-27 |
Family
ID=76838879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025789A BR112023025789A2 (pt) | 2021-06-09 | 2022-06-09 | Nitroxolina para uso no tratamento de neurofibroma cutâneo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240261276A1 (https=) |
| EP (1) | EP4351576A1 (https=) |
| JP (1) | JP2024520690A (https=) |
| KR (1) | KR20240024175A (https=) |
| CN (1) | CN117769419A (https=) |
| AU (1) | AU2022290019A1 (https=) |
| BR (1) | BR112023025789A2 (https=) |
| CA (1) | CA3221964A1 (https=) |
| GB (1) | GB202108224D0 (https=) |
| IL (1) | IL309177A (https=) |
| MX (1) | MX2023014530A (https=) |
| WO (1) | WO2022258972A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202116743D0 (en) * | 2021-11-19 | 2022-01-05 | Healx Ltd | Treatment |
| GB202218460D0 (en) * | 2022-12-08 | 2023-01-25 | Healx Ltd | Treatment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3039822C (en) * | 2016-10-14 | 2026-02-17 | Wake Forest University Health Sciences | Compositions, cell constructs, and methods of making and using the same |
-
2021
- 2021-06-09 GB GBGB2108224.3A patent/GB202108224D0/en not_active Ceased
-
2022
- 2022-06-09 BR BR112023025789A patent/BR112023025789A2/pt unknown
- 2022-06-09 KR KR1020247000745A patent/KR20240024175A/ko active Pending
- 2022-06-09 MX MX2023014530A patent/MX2023014530A/es unknown
- 2022-06-09 AU AU2022290019A patent/AU2022290019A1/en active Pending
- 2022-06-09 US US18/567,829 patent/US20240261276A1/en active Pending
- 2022-06-09 EP EP22732622.0A patent/EP4351576A1/en active Pending
- 2022-06-09 WO PCT/GB2022/051442 patent/WO2022258972A1/en not_active Ceased
- 2022-06-09 CA CA3221964A patent/CA3221964A1/en active Pending
- 2022-06-09 CN CN202280040639.5A patent/CN117769419A/zh active Pending
- 2022-06-09 IL IL309177A patent/IL309177A/en unknown
- 2022-06-09 JP JP2023574531A patent/JP2024520690A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB202108224D0 (en) | 2021-07-21 |
| CN117769419A (zh) | 2024-03-26 |
| CA3221964A1 (en) | 2022-12-15 |
| EP4351576A1 (en) | 2024-04-17 |
| AU2022290019A1 (en) | 2023-12-14 |
| MX2023014530A (es) | 2024-04-10 |
| WO2022258972A1 (en) | 2022-12-15 |
| JP2024520690A (ja) | 2024-05-24 |
| KR20240024175A (ko) | 2024-02-23 |
| US20240261276A1 (en) | 2024-08-08 |
| IL309177A (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ777871A (en) | Small molecule modulators of il-17 | |
| ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
| CL2021000382A1 (es) | Compuestos novedosos de sulfonamidaurea | |
| UA130338C2 (uk) | Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування | |
| CL2018002009A1 (es) | Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras. | |
| BR112019024831A2 (pt) | composto, sal, solvato ou pró-droga, composição farmacêutica, método de tratamento ou prevenção de uma doença, método para inibir o nlrp3 | |
| CL2020000860A1 (es) | Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas. | |
| MX2023014492A (es) | Compuestos utiles en la terapia para el vih. | |
| MX2019012847A (es) | Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer. | |
| MY202753A (en) | Griseofulvin compound and pharmaceutical use thereof | |
| BR112019004236A2 (pt) | compostos para tratar doenças associadas a uma disfunção mitocondrial | |
| BR112019018615A2 (pt) | compostos antimicrobianos, composições e usos dos mesmos | |
| BR112023025789A2 (pt) | Nitroxolina para uso no tratamento de neurofibroma cutâneo | |
| MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
| BR112018070536A2 (pt) | composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição | |
| BR112021011325A2 (pt) | Derivados de rapamicina | |
| BR112022020933A2 (pt) | Inibidores de replicação do vírus da imunodeficiência humana | |
| BR112022019864A2 (pt) | Composto de oxofenilarsina deuterada e uso do mesmo | |
| BR112018070514A2 (pt) | composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição | |
| BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
| MX2024006105A (es) | Nitroxolina para su uso en el tratamiento o prevencion de un neurofibroma plexiforme. | |
| BR112018073419A2 (pt) | combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica | |
| CL2019001618A1 (es) | Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar. | |
| JOP20230099A1 (ar) | تركيبات صيدلية | |
| BR112018007374A2 (pt) | composição farmacêutica |